MCKESSON CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 555.8 USD | +1.84% |
|
+1.59% | +17.88% |
| 02:09pm | Leerink Adjusts Price Target on McKesson to $617 From $606, Keeps Outperform Rating | MT |
| 02:09pm | Barclays Adjusts Price Target on McKesson to $596 From $571, Keeps Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
13/05/2024
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
545.8
USD
Average target price
570
USD
Spread / Average Target
+4.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.88% | 71.72B | |
| -1.07% | 24.29B | |
| +8.01% | 8.31B | |
| -18.28% | 8.22B | |
| +1.47% | 8.16B | |
| +4.52% | 4.76B | |
| +16.55% | 4.31B | |
| -0.70% | 4.1B | |
| -2.27% | 3.91B | |
| +26.24% | 3.78B |
- Stock Market
- Equities
- MCK Stock
- News McKesson Corporation
- McKesson : Three US Opioid Distributors Settle Opioid-Related Claims With Cherokee Nation
